Renal Effects of CB3717 and ICI D1694 in Mice
Author Information
Author(s): D.I. Jodrell, D.R. Newell, S.E. Morgan, S. Clinton, J.P.M. Bensted, L.R. Hughes, A.H. Calvert
Primary Institution: Institute of Cancer Research
Hypothesis
The study aims to assess the nephrotoxicity of CB3717 and the renal effects of its non-nephrotoxic analogue ICI D1694 in mice.
Conclusion
CB3717 causes dose-related nephrotoxicity, while ICI D1694 is non-nephrotoxic even after repeated administration.
Supporting Evidence
- CB3717 caused a significant reduction in GFR after administration.
- ICI D1694 showed no evidence of renal damage after repeated doses.
- Histological examination revealed persistent renal damage from CB3717.
- Measurement of GFR was more sensitive than plasma urea and creatinine levels.
Takeaway
This study found that one drug can hurt the kidneys while another similar drug does not, helping us understand how to make safer medicines.
Methodology
The study used a '4C-inulin clearance assay to measure glomerular filtration rate (GFR) in mice after administering CB3717 and ICI D1694.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
C57/DBA2 and Balb C mice were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website